GRAIL, Inc. is a healthcare company that focuses on improving health and saving lives by pioneering new technologies for early cancer detection. The company’s mission is to detect cancer early on to make it easier to cure. As an employer, GRAIL, Inc. has offered full-time, 100% remote jobs in the past. Eligible roles may receive perks and benefits, including health insurance and flexible time off. GRAIL’s team is made up of dedicated and passionate professionals that are committed to education, collaboration, and problem-solving. Team members are drawn together by their shared belief in making a positive impact on people’s lives.

Founded in 2016, GRAIL, Inc. is headquartered in Menlo Park, California, with additional offices in North Carolina; Washington, DC; and the United Kingdom. The company uses population-scale clinical studies, next-generation sequencing, and state-of-the-art data science and computer science to develop Galleri, an early detection blood test that can recognize over 50 different types of cancers. Since the blood test has a low false-positive rate, it also decreases the risks associated with false alarms. GRAIL is also developing solutions to help accelerate cancer diagnoses and other post-diagnostic applications. The company is supported by pharmaceutical, healthcare, and technology partners, including Cleveland Clinic, Oregon Health & Science University, and Sutter Health.

GRAIL, Inc. is a healthcare company that focuses on improving health and saving lives by pioneering new technologies for early cancer detection. The company’s mission is to detect cancer early on to make it easier to cure. As an employer, GRAIL, Inc. has offered full-time, 100% remote jobs in the past. Eligible roles may receive perks and benefits, including health insurance and flexible time off. GRAIL’s team is made up of dedicated and passionate professionals that are committed to education, collaboration, and problem-solving. Team members are drawn together by their shared belief in making a positive impact on people’s lives.

Founded in 2016, GRAIL, Inc. is headquartered in Menlo Park, California, with additional offices in North Carolina; Washington, DC; and the United Kingdom. The company uses population-scale clinical studies, next-generation sequencing, and state-of-the-art data science and computer science to develop Galleri, an early detection blood test that can recognize over 50 different types of cancers. Since the blood test has a low false-positive rate, it also decreases the risks associated with false alarms. GRAIL is also developing solutions to help accelerate cancer diagnoses and other post-diagnostic applications. The company is supported by pharmaceutical, healthcare, and technology partners, including Cleveland Clinic, Oregon Health & Science University, and Sutter Health.